CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 92  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0911
LYS 10.0286
GLU 20.0273
LEU 30.0237
ARG 40.0353
CYS 50.0062
GLN 60.0201
CYS 70.0911
ILE 80.0246
LYS 90.0235
THR 100.0066
TYR 110.0045
SER 120.0165
LYS 130.0361
PRO 140.0116
PHE 150.0060
HIS 160.0087
PRO 170.0096
LYS 180.0210
PHE 190.0112
ILE 200.0047
LYS 210.0112
GLU 220.0093
LEU 230.0126
ARG 240.0210
VAL 250.0257
ILE 260.0207
GLU 270.0339
SER 280.0123
GLY 290.0356
PRO 300.0630
HIS 310.0429
CYS 320.0310
ALA 330.0167
ASN 340.0275
THR 350.0246
GLU 360.0147
ILE 370.0080
ILE 380.0045
VAL 390.0079
LYS 400.0121
LEU 410.0089
SER 420.0093
ASP 430.0058
GLY 440.0163
ARG 450.0138
GLU 460.0137
LEU 470.0081
CYS 480.0052
LEU 490.0074
ASP 500.0139
PRO 510.0246
LYS 520.0080
GLU 530.0200
ASN 540.0143
TRP 550.0053
VAL 560.0026
GLN 570.0085
ARG 580.0079
VAL 590.0078
VAL 600.0098
GLU 610.0067
LYS 620.0033
PHE 630.0024
LEU 640.0049
LYS 650.0116
ARG 660.0044
ALA 670.0269
GLU 680.0215
ASN 690.0196

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.